This inventor holds 1 USPTO granted patent. Top assignee: King's College London. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Johan Verhagen
Introduction
Johan Verhagen is a notable inventor based in London, GB. He has made significant contributions to the field of diabetes research, particularly in the development of proinsulin peptides for Type I Diabetes. His work is crucial in advancing treatment options for individuals affected by this condition.
Latest Patents
Johan Verhagen holds a patent for "Proinsulin Peptides for Type I Diabetes." This innovation aims to improve the management of diabetes by providing new therapeutic avenues for patients.
Career Highlights
Verhagen is affiliated with King's College London, where he conducts research and collaborates with other experts in the field. His dedication to advancing medical science is evident through his innovative work and commitment to improving patient outcomes.
Collaborations
Some of his notable coworkers include Mark Peakman and Martin Eichmann. Their collaborative efforts contribute to the ongoing research and development in diabetes treatment.
Conclusion
Johan Verhagen's contributions to diabetes research through his patent and work at King's College London highlight his commitment to innovation in medical science. His efforts are paving the way for better treatment options for those living with Type I Diabetes.